Tag: Pharmacy

FDA Says Pharmacies Can Still Compound Generic Makena

Pharmacies can continue to compound generic hydroxyprogesterone caproate for reducing the risk for preterm delivery despite warnings from KV Pharmaceutical — which sells a costly, branded version of the drug — not to do so, the US Food and Drug Administration (FDA) announced today. On February 3, the FDA approved KV Pharmaceutical’s Makena, an injectable form of hydroxyprogesterone…

Read More
© 2024 Neera Bhatia MD OBGYN. All Rights Reserved. San Antonio Website Design & Development - Backyard Studios